Socio-demographic characteristics of the population. by Sara Saleh (6733619)

Subjects:

Knowledge, attitude and practice scores in the general population and according to regions. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Subjects:

Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the knowledge scores. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the attitude scores. by Sara Saleh (6733619)

Subjects:

Multivariate analysis of sociodemographic and other factors associated with the KAP scores. by Sara Saleh (6733619)

Subjects:

Participants’ perceived ways to boost children’s immune system other than vaccination. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the practice scores. by Sara Saleh (6733619)

Subjects:

Mean (±SD) sugar consumption (µL/bee) of adult summer worker bees (n = 180/group) over time (in days) after inoculation with A. one of 6 incremental doses of of <i>M. plutonius</i>... by Midhun Sebastian Jose (19336846)

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. by Kevin J. Johnson (2647639)

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each WAD group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each intervention group, and within-group effects. by Anneli Peolsson (7867601)

Subjects: